Literature DB >> 23473730

Performance of individual items of the quantitative myasthenia gravis score.

T Carolina Barnett1, Vera Bril, Aileen M Davis.   

Abstract

We evaluated the quantitative myasthenia gravis score to determine which items better discriminate among patients and are most responsive to treatment. Current scoring ranges were compared to updated normative data when appropriate. Data from a previous study of intravenous immunoglobulin versus placebo in myasthenia gravis were analyzed. Each item of the quantitative myasthenia gravis score was analyzed for distribution, responsiveness and inter-item correlations. Items on swallowing, speaking and vital capacity had marked floor effects as did grip strength based on current normative data. The timed measures were responsive to treatment but diplopia, vital capacity and grip strength were not. Ocular items were not correlated with bulbar and generalized items (p>0.05), suggesting multi-dimensionality. Contralateral arm and leg tests were highly correlated (r>0.9, p<0.001), indicating redundancy. In summary, we found that the bulbar items and grip strength did not perform well. Timed items from the Quantitative Myasthenia Gravis Score, representing fatigability, are responsive to change and we propose new ranges based on updated normative data.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473730     DOI: 10.1016/j.nmd.2013.02.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  A conceptual framework for evaluating impairments in myasthenia gravis.

Authors:  Carolina Barnett; Vera Bril; Moira Kapral; Abhaya Kulkarni; Aileen M Davis
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

2.  Development and validation of the Myasthenia Gravis Impairment Index.

Authors:  Carolina Barnett; Vera Bril; Moira Kapral; Abhaya Kulkarni; Aileen M Davis
Journal:  Neurology       Date:  2016-07-08       Impact factor: 9.910

3.  Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale.

Authors:  Carolina Barnett; Ingemar S J Merkies; Hans Katzberg; Vera Bril
Journal:  J Neuromuscul Dis       Date:  2015-09-02

4.  Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.

Authors:  Robert H P de Meel; Carolina Barnett; Vera Bril; Martijn R Tannemaat; Jan J G M Verschuuren
Journal:  J Neuromuscul Dis       Date:  2020

5.  Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.

Authors:  Gary Cutter; Haichang Xin; Inmaculada Aban; Ted M Burns; Phillip H Allman; Ramin Farzaneh-Far; Petra W Duda; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2019-10-09       Impact factor: 3.217

6.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

7.  Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study.

Authors:  Jinghao Li; Senhui Weng; Sen Lin; Linwen Huang; Xiaojun Yang; Bo Liang; Jiaxin Lu; Qilong Jiang
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

8.  Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.

Authors:  Carolina Barnett; Vera Bril; Moira Kapral; Abhaya V Kulkarni; Aileen M Davis
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.